Search Results - "Laban, Simon"

Analysis, identification and visualization of subgroups in genomics.

Authors: Völkel, Gunnar Laban, Simon Fürstberger, Axel et al.

Source: Briefings in Bioinformatics. May2021, Vol. 22 Issue 3, p1-12. 12p.

Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).

Authors: Bußmann, Lara Laban, Simon Wittekindt, Claus et al.

Source: BMC Cancer. 7/29/2020, Vol. 20 Issue 1, p1-13. 13p. 1 Diagram, 2 Charts.

Novel Treatment Options in Head and Neck Cancer.

Authors: Schuler, Patrick J. Laban, Simon Doescher, Johannes et al.

Source: Oncology Research & Treatment. Jun2017, Vol. 40 Issue 6, p342-346. 5p.

Identification of B Cell Subpopulations with Pro- and Anti-Tumorigenic Properties in an Immunocompetent Mouse Model of Head and Neck Squamous Cell Carcinoma.

Authors: Sonntag, Michael Stanojevic, Sandra Laban, Simon et al.

Source: Cells (2073-4409). Jan2025, Vol. 14 Issue 1, p20. 22p.

Erratum to: Analysis, identification and visualization of subgroups in genomics.

Authors: Völkel, Gunnar Laban, Simon Fürstberger, Axel et al.

Source: Briefings in Bioinformatics. Nov2021, Vol. 22 Issue 6, p1-1. 1p.

Surgery of T1/2 N0 M0 glottic cancer results in a better laryngeal preservation time compared to radiotherapy in a large German patient cohort.

Authors: Ketterer, Manuel Christoph Hoffmann, Thomas K. Laban, Simon et al.

Source: European Archives of Oto-Rhino-Laryngology. Dec2025, Vol. 282 Issue 12, p6645-6653. 9p.

Immuntherapie im Kontext anderer Therapiemodalitäten von Kopf-Hals-Tumoren – Highlights der ASCO- und ESMO-Jahrestagung 2022.

Alternate Title: Immunotherapy in the context of other head and neck cancer treatment modalities—highlights of the ASCO and ESMO annual meeting 2022.

Authors: von Witzleben, Adrian Hoffmann, Thomas K. Laban, Simon

Source: Best Practice Onkologie. Oct2023, Vol. 18 Issue 10, p462-467. 6p.

Characterization and Differentiation of the Tumor Microenvironment (TME) of Orthotopic and Subcutaneously Grown Head and Neck Squamous Cell Carcinoma (HNSCC) in Immunocompetent Mice.

Authors: Brand, Matthias Laban, Simon Theodoraki, Marie-Nicole et al.

Source: International Journal of Molecular Sciences. Jan2021, Vol. 22 Issue 1, p247. 1p.

Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation.

Authors: Laban, Simon Steinmeister, Leonhard Gleißner, Lisa et al.

Source: Radiotherapy & Oncology. Nov2013, Vol. 109 Issue 2, p286-292. 7p.

Subjects: Nicotinamide, Head & neck cancer treatment, Cancer cells, Cancer radiotherapy, Health outcome assessment, Cancer chemotherapy, Combination drug therapy

Evaluation of Customized Prosthesis for Irregularly Formed Tracheostoma After Laryngectomy.

Authors: Doescher, Johannes Scheckenbach, Kathrin Angerstein, Wolfgang et al.

Source: Annals of Otology, Rhinology & Laryngology. Feb2016, Vol. 125 Issue 2, p145-150. 6p.

Subjects: Prosthetics, Laryngectomy, Questionnaires, Human voice, Tracheotomy equipment

Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature.

Authors: Zielinski, Valerie Laban, Simon Tribius, Silke et al.

Source: ENT: Ear, Nose & Throat Journal. Jan2016, Vol. 95 Issue 1, p23-28. 6p.

Co-Stimulatory and Immune Checkpoint Molecule Expression on Peripheral Immune Cells Differs Age Dependently Between Healthy Donors and Patients with Head and Neck Squamous Cell Carcinoma.

Authors: Puntigam, Lisa K. Grages, Ayla Vahl, Julius M. et al.

Source: Cancers. Oct2025, Vol. 17 Issue 19, p3215. 13p.

Cytotoxic natural antibodies against human tumours: An option for anti-cancer immunotherapy?

Authors: Schwartz-Albiez, Reinhard Laban, Simon Eichmüller, Stefan et al.

Source: Autoimmunity Reviews. Jun2008, Vol. 7 Issue 6, p491-495. 5p.

Treatment regimens for laryngeal and hypopharyngeal squamous cell carcinoma: a "real life" multicenter study of 2307 patients.

Authors: Knopf, Andreas Ketterer, Manuel Christoph Hoffmann, Thomas K. et al.

Source: European Archives of Oto-Rhino-Laryngology. Dec2025, Vol. 282 Issue 12, p6609-6621. 13p.

Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern Germany.

Authors: Vahl, Julius M. Nagel, Gabriele Abou Kors, Tsima et al.

Source: Cancer Medicine. Dec2023, Vol. 12 Issue 23, p21426-21435. 10p.

Demographics and access to head and neck cancer care in rural areas compared to urban areas in Germany.

Authors: Vahl, Julius M. Nagel, Gabriele Grages, Ayla et al.

Source: Cancer Medicine. Sep2023, Vol. 12 Issue 18, p18826-18836. 11p.

Influence of Bruton's Tyrosine Kinase (BTK) on Epithelial–Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC).

Authors: Leichtle, Franziska Betzler, Annika C. Eizenberger, Carlotta et al.

Source: International Journal of Molecular Sciences. Sep2023, Vol. 24 Issue 17, p13133. 15p.

BTK Isoforms p80 and p65 Are Expressed in Head and Neck Squamous Cell Carcinoma (HNSCC) and Involved in Tumor Progression.

Authors: Betzler, Annika C. Strobel, Hannah Abou Kors, Tsima et al.

Source: Cancers. Jan2023, Vol. 15 Issue 1, p310. 19p.

Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions.

Authors: von Witzleben, Adrian Müller-Richter, Urs Maurus, Katja et al.

Source: International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 24, p15835. 11p.

Patterns of Tumor Infiltrating Lymphocytes in Adenoid Cystic Carcinoma of the Head and Neck.

Authors: Doescher, Johannes Meyer, Moritz Arolt, Christoph et al.

Source: Cancers. Mar2022, Vol. 14 Issue 6, p1383. 12p.